Washington: Researchers including an Indian origin have shed some light on why aspirin benefits some people and not others.Researchers at Duke Medicine developed a blood-based test of gene activity that has been shown to accurately identify who will respond to the therapy.The study showed that the new gene expression profile not only measures the effectiveness of aspirin, but also serves as a strong predictor of patients who are at risk for heart attack.The Duke researchers enlisted three groups of participants - two of healthy volunteers and one comprised of patients with heart disease seen in outpatient cardiology practices.
MEMD: Gadkari, Uma Bharti join the campaign
PM Narendra Modi addresses DRDO scientists
Sonia Gandhi targets PM Modi yet again
PM Narendra Modi`s Parliamentary office to be inaugurated in Varanasi today